Tesla Motors Inc (NASDAQ:TSLA) a year after creating a lease-style program for its Model S electric sedan, is setting up a financing arm targeted at corporate buyers of the premium battery-powered vehicle. Tesla Motors Inc (NASDAQ:TSLA) shares after opening at $205.81 moved to $216.20 on last trade day and at the end of the day closed at $207.52. Company price to sales ratio in past twelve months was calculated as 12.70 and price to cash ratio as 30.22. Tesla Motors Inc (NASDAQ:TSLA) showed a negative weekly performance of -0.45%.
U.S. Trust, Bank of America Private Wealth Management, as Trustee of the Cross Timbers Royalty Trust (NYSE:CRT), declared a cash distribution to the holders of its units of beneficial interest of $0.261392 per unit, payable on April 14, 2014, to unitholders of record on March 31, 2014. Cross Timbers Royalty Trust (NYSE:CRT) shares fell -0.65 % in last trading session and ended the day on $ 30.75. return on equity ratio is recorded as 132.00 % and its return on assets is 120.20 %. Cross Timbers Royalty Trust (NYSE:CRT) yearly performance is 15.82 %.
US Ecology (NASDAQ:ECOL) was upgraded by stock analysts at KeyCorp from a “hold” rating to a “buy” rating in a report issued on Tuesday, Stock Ratings Network reports. US Ecology Inc (NASDAQ:ECOL) shares moved down -0.69% in last trading session and was closed at $35.74 while trading in range of $35.26 – $38.08 – US Ecology Inc (NASDAQ:ECOL) year to date (YTD) performance is -3.20%.
Oncothyreon Inc. (NASDAQ:ONTY) announced that Merck KGaA, Darmstadt, Germany, has initiated the international Phase 3 START2 study, which is designed to assess the efficacy and safety of the investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) in patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC). Oncothyreon Inc (US) (NASDAQ:ONTY) on last trading day company shares ended up $2.99. Oncothyreon Inc (USA) (NASDAQ:ONTY) distance from 50-day simple moving average (SMA50) is 0.34%. Analysts mean target price for the company is $6.00.